Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Ansell

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Joint Commission Journal on Quality and Patient Safety|February 8, 2022
Virtual Education for Patient Self-Testing for Warfarin Therapy Is Effective During the COVID-19 PandemicErika Leemann Price, Jack Ansell
Current Hematology Reports|September 1, 2005
Cancer and thrombosisElisabeth M Battinelli, Jack Ansell
Expert Review of Cardiovascular Therapy|December 22, 2007
Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality managementKatherine W Phillips, Jack Ansell
Thrombosis and Haemostasis|January 12, 2010
The clinical implications of new oral anticoagulants: will the potential advantages be achieved?Katherine W Phillips, Jack Ansell
Current Opinion in Hematology|June 25, 2009
Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of changeJennifer Carreiro Zikria, Jack Ansell
Evidence-Based Medicine|April 5, 2011
Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complicationsDavid J Rosenberg, Jack Ansell
Journal of Thrombosis and Haemostasis : JTH|May 22, 2026
A Light in the Dark - Reframing DOAC Pharmacokinetics and Pharmacodynamics for Near-Patient Decision-MakingJoseph R Shaw, Jack Ansell
Hospital Practice (1995)|October 23, 2012
Target-specific oral anticoagulants for stroke prevention in patients with atrial fibrillation: real-world considerationsDavid J Rosenberg, Jack Ansell
Nature Reviews. Cardiology|February 29, 2012
Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillationKatherine P Cabral, Jack Ansell
The Journal of the Michigan Dental Association|December 6, 2012
Kudos on anticoagulation issueRandy Fenninger, Jack Ansell, Alan Brownstein
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Joint Commission Journal on Quality and Patient Safety|February 8, 2022
Virtual Education for Patient Self-Testing for Warfarin Therapy Is Effective During the COVID-19 PandemicErika Leemann Price, Jack Ansell
Current Hematology Reports|September 1, 2005
Cancer and thrombosisElisabeth M Battinelli, Jack Ansell
Expert Review of Cardiovascular Therapy|December 22, 2007
Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality managementKatherine W Phillips, Jack Ansell
Thrombosis and Haemostasis|January 12, 2010
The clinical implications of new oral anticoagulants: will the potential advantages be achieved?Katherine W Phillips, Jack Ansell
Current Opinion in Hematology|June 25, 2009
Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of changeJennifer Carreiro Zikria, Jack Ansell
Evidence-Based Medicine|April 5, 2011
Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complicationsDavid J Rosenberg, Jack Ansell
Journal of Thrombosis and Haemostasis : JTH|May 22, 2026
A Light in the Dark - Reframing DOAC Pharmacokinetics and Pharmacodynamics for Near-Patient Decision-MakingJoseph R Shaw, Jack Ansell
Hospital Practice (1995)|October 23, 2012
Target-specific oral anticoagulants for stroke prevention in patients with atrial fibrillation: real-world considerationsDavid J Rosenberg, Jack Ansell
Nature Reviews. Cardiology|February 29, 2012
Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillationKatherine P Cabral, Jack Ansell
The Journal of the Michigan Dental Association|December 6, 2012
Kudos on anticoagulation issueRandy Fenninger, Jack Ansell, Alan Brownstein
Pageof 12